Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The 17beta-hydroxysteroid dehydrogenase (17betaHSD) enzyme system governs important redox reactions at the C17 position of steroid hormones. Different 17betaHSD types (no. 1-4) have been identified to date in peripheral human tissues, such as placenta, testis, and breast. However, there is little information on their expression and activity in either normal or malignant prostate. In the present work, we have inspected pathways of 17beta-oxidation of either androgen or estrogen in human prostate cancer cells (LNCaP, DU145, and PC3) in relation to the expression of messenger RNAs (mRNAs) for 17betaHSD types 1-4. These cell systems feature distinct steroid receptor status and response to hormones. We report here that high expression levels of 17betaHSD4 were consistently observed in all three cell lines, whereas even greater amounts of 17betaHSD2 mRNA were detected solely in PC3 cells. Neither 17betaHSD1 nor 17betaHSD3 mRNAs could be detected in any cell line. From a metabolic standpoint, intact cell analysis showed a much lower extent of 17beta-oxidation of both androgen [testosterone (T)] and estrogen [estradiol (E2)] in LNCaP and DU145 cells compared to PC3 cells, where a greater precursor degradation and higher formation rates of oxidized derivatives (respectively, androstenedione and estrone) were observed. Using subcellular fractionation, we have been able to differentiate among 17betaHSD types 1-4 on the basis of their distinct substrate specificities and subcellular localization. This latter approach gave rise to equivalent results. PC3 cells, in fact, displayed a high level of microsomal activity with a low E2/T activity ratio and approximately equal apparent Km values for E2 and T, suggesting the presence of 17betaHSD2. Dehydrogenase specific activity with both E2 and T was also detected, although at lower levels, in LNCaP and DU145 cells. No evidence for reductase activity could be obtained in either the soluble or microsomal fraction of any cell line. As comparable expression levels of 17betaHSD4 were seen in the three cell lines, 17betaHSD2 is a likely candidate to account for the predominant oxidative activity in PC3 cells, whereas 17betaHSD4 may account for the lower extent of E2 oxidation seen in both LNCaP and DU145 cells. This is the first report on the expression of four different 17betaHSD types in human prostate cancer cells. It ought to be emphasized that for the first time, analysis of different 17betaHSD activities in either intact or fractionated cells harmonizes with the expression of relevant mRNAs species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
Wu, L., Einstein, M., Geissler, W. M., Chan, H. K., Elliston, K. O., & Andersson, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31480-7 · Cited by 437
Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
Peltoketo, H., Isomaa, V., Mäentausta, O., & Vihko, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80548-9 · Cited by 294
Molecular cloning of a novel widely expressed human 80 kDa 17 β -hydroxysteroid dehydrogenase IV
Adamski, J., Normand, T., Leenders, F., Monté, D., Begue, A., Stéhelin, D., Jungblut, P. W., & de Launoit, Y. (1995) · Biochemical Journal · doi:10.1042/bj3110437 · Cited by 214
Self-citationCasey, M. L., MacDonald, P. C., & Andersson, S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117569 · Cited by 212
Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes
Luu-The, V., Labrie, C., Simard, J., Lachance, Y., Zhao, H.-F., Couët, J., Leblanc, G., & Labrie, F. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-2-268 · Cited by 173
Leenders, F., Tesdorpf, J. G., Markus, M., Engel, T., Seedorf, U., & Adamski, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5438 · Cited by 116
Self-citation
Research works printed but not linked: 29
- Andersson, 1995, 17β-Hydroxysteroid dehydrogenases: isozymes and mutations., J Endocrinol, 146, 197, 10.1677/joe.0.1460197 · DOI · Paper page
- Reed, 1991, Oestradiol 17β-hydroxysteroid dehydrogenase: its family and function., J Endocrinol, 129, 163, 10.1677/joe.0.1290163 · DOI
- Luu-The, 1989, Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta., Mol Endocrinol, 3, 1301, 10.1210/mend-3-8-1301 · DOI · Paper page
- Adamski, 1992, Purification and properties of oestradiol 17β-dehydrogenase extracted from cytoplasmic vesicles of porcine endometrial cells., Biochem J, 288, 375, 10.1042/bj2880375 · DOI · Paper page
- Leenders, 1994, The sequence of porcine 80 kDa 17β-estradiol dehydrogenase reveals similarities to the short chain alcohol dehydrogenase family, to actin binding motifs and to sterol carrier protein 2., Mol Cell Endocrinol, 104, 127, 10.1016/0303-7207(94)90114-7 · DOI
- Normand, 1995, Molecular characterization of mouse 17β-hydroxysteroid dehydrogenase IV., J Steroid Biochem Mol Biol, 55, 541, 10.1016/0960-0760(95)00204-9 · DOI
- Bartsch, 1990, Enzymes of androgen formation and degradation in the human prostate., Ann NY Acad Sci, 595, 53, 10.1111/j.1749-6632.1990.tb34282.x · DOI
- Klein, 1991, Endocrine-Dependent Tumors, 131
- Krieg, 1979, A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate., J Steroid Biochem, 11, 615, 10.1016/0022-4731(79)90090-6 · DOI
- D’Agostino, 1984, Solvent optimization for RP-HPLC of polar adrenal steroids using computer predicted retention for a modified COF procedure., J Chromatogr, 305, 13, 10.1016/S0378-4347(00)83310-1 · doi:10.1016/s0378-4347(00)83310-1
- D’Agostino, 1985, Computer-aided mobile phase optimization and chromatogram simulation in high-performance liquid chromatography., J Chromatogr, 338, 1, 10.1016/0378-4347(85)80065-7 · doi:10.1016/0378-4347(85)80065-7
- Castagnetta, 1991, Simple approach to measure metabolic pathways of steroids in living cells., J Chromatogr, 572, 25, 10.1016/0378-4347(91)80470-W · DOI
- Castagnetta, 1994, Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells., J Steroid Biochem Mol Biol, 49, 351, 10.1016/0960-0760(94)90279-8 · doi:10.1016/0960-0760(94)90279-8
- Castagnetta, 1995, Oxidative and reductive pathways in hormone responsive and non-responsive human breast cancer cells in vitro., J Steroid Biochem Mol Biol, 53, 367, 10.1016/0960-0760(95)00081-A · doi:10.1016/0960-0760(95)00081-a
- Castagnetta, 1995, 17β-Hydroxysteroid dehydrogenase activity in endometrial cancer cells: different metabolic pathways of estradiol in hormone-responsive and non-responsive intact cells., J Steroid Biochem Mol Biol, 55, 573, 10.1016/0960-0760(95)00208-1 · doi:10.1016/0960-0760(95)00208-1
- Castagnetta, 1986, Estrone conversion rates by human endometrial cancer cell lines., J Steroid Biochem, 25, 803, 10.1016/0022-4731(86)90312-2 · doi:10.1016/0022-4731(86)90312-2
- Adams, 1988, Metabolic fate of estradiol in human mammary cancer cells in culture: estrogen sulfate formation and cooperativity exhibited by estrogen sulfotransferase., Mol Cell Endocrinol, 58, 231, 10.1016/0303-7207(88)90159-1 · DOI
- Blomquist, 1995, Properties and regulation of 17β-hydroxysteroid dehydrogenase oxidoreductase of OVCAR-3, CAOV-3 and A431 cells: effects of epidermal growth factor, estradiol and progesterone., J Cell Biochem, 59, 409, 10.1002/jcb.240590402 · DOI
- Blomquist, 1994, A comparison of 17β-hydroxysteroid oxidoreductase type 1 and type 2 activity of cytosol and microsomes from human term placenta, ovarian stroma and granulosa-luteal cells., J Steroid Biochem Mol Biol, 49, 183, 10.1016/0960-0760(94)90009-4 · DOI
- Markwell, 1981, Protein determination in membrane and lipoprotein samples: manual and automated procedures., Methods Enzymol, 72, 296, 10.1016/S0076-6879(81)72018-4 · DOI · Paper page
- Cornish-Bowden, 1978, Michaelis constant and maximum velocity from the direct linear plot., Biochim Biophys Acta, 523, 268, 10.1016/0005-2744(78)90030-X · DOI · Paper page
- Blomquist, 1995, Prediction of multiple forms of 17β-hydroxysteroid dehydrogenase., J Steroid Biochem Mol Biol, 55, 515, 10.1016/0960-0760(95)00200-6 · DOI
- Pylkkanen, 1996, Immunohistochemical localization of estrogen-specific 17β-hydroxysteroid oxidoreductase in the human and mouse prostate., Prostate, 25, 292, 10.1002/pros.2990250603 · doi:10.1002/pros.2990250603
- Delos, 1995, Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts., J Steroid Biochem Mol Biol, 55, 375, 10.1016/0960-0760(95)00184-0 · DOI
- Carruba, 1994, Steroid-growth factor interaction in human prostate cancer. I. Short-term effects of transforming growth factors on growth of human prostate cancer cells., Steroids, 59, 412, 10.1016/0039-128X(94)90010-8 · doi:10.1016/0039-128x(94)90010-8
- Castagnetta, 1995, Growth of LNCaP cells is stimulated by estradiol via its own receptor., Endocrinology, 136, 2309, 10.1210/endo.136.5.7536668 · doi:10.1210/endo.136.5.7536668
- Carstensen, 1996, Characterization of 17β-hydroxysteroid dehydrogenase IV, J Endocrinol [Suppl], 150, S3
- Bradlow, 1995, Effect of serum albumin on estrogen metabolism in human cancer cell lines., Mol Cell Endocrinol, 115, 221, 10.1016/0303-7207(95)03684-9 · doi:10.1016/0303-7207(95)03684-9
- Carruba, 1994, Estradiol inhibits growth of hormone non responsive PC3 human prostate cancer cells., Cancer Res, 54, 1190
Cited by
The role of 17 beta-hydroxysteroid dehydrogenases
Mindnich, R., Möller, G., & Adamski, J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.12.006 · Cited by 354
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1
Dufort, I., Rheault, P., Huang, X.-F., Soucy, P., & Luu-The, V. (1999) · Endocrinology · doi:10.1210/endo.140.2.6531 · Cited by 255
Attard, G., Belldegrun, A. S., & De Bono, J. S. (2005) · BJU International · doi:10.1111/j.1464-410x.2005.05821.x · Cited by 207
Rižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M. (2003) · Endocrinology · doi:10.1210/en.2002-0032 · Cited by 132
Metadata
- Authors
- Castagnetta, L. A. M., Carruba, G., Traina, A., Granata, O. M., Markus, M., Pavone-Macaluso, M., Blomquist, C. H., & Adamski, J.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1997-11-01
- Volume
- 138
- Issue
- 11
- Pages
- 4876-4882
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2060524703
- Cited by
- 45
- References
- 7
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*. https://app.cochat.ai/papers/10.1210/endo.138.11.5497
- The paper
- Castagnetta, L. A. M., Carruba, G., Traina, A., Granata, O. M., Markus, M., Pavone-Macaluso, M., Blomquist, C. H., & Adamski, J. (1997). Expression of Different 17β-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells*. Endocrinology. https://doi.org/10.1210/endo.138.11.5497
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.